高用量の抗酸化物質を含む栄養補助食品の試験の一つ、"Supplémentation en Vitamines et Mineraux Antioxydants" (SU.VI.MAX) study は、いわゆる健康食に相当する栄養を補足し、その効果を調査する試験である[218]。この試験では、12,500人のフランス人の男女を対象に、低用量の抗酸化物質(アスコルビン酸:120 mg、ビタミンE:30 mg、β-カロテン:6 mg、セレン:100 μg、亜鉛:20mg)または偽薬を平均7.5年間摂取させた。結果、癌および心臓疾患に対し統計学的に見て抗酸化物質には大きな効果は認められなかった。事後分析では男性では31%の癌リスクの減少が見られたが、女性では見られなかった。これは、試験を開始した段階での血液検査の結果から試験開始当初の時点で女性被験者の方が男性被験者よりもビタミンE や β-カロテンの血中濃度が高かったことが判明しており、男性と女性で状態が初めから異なっていたためである[236]。
例えば、味噌には放射能防御能力があることが報告されている[262][263][264][信頼性要検証]。動物実験では、十分に熟成した味噌ほど放射線防御作用が高いと言われている[153][265]。また、レスベラトロールに放射線障害を防ぐ働きがあることが、ピッツバーグ大学の Joel Greenberger のマウスを使った研究で報告している[266][信頼性要検証]。
^ abDavies K (1995). “Oxidative stress: the paradox of aerobic life”. Biochem Soc Symp61: 1–31. PMID 8660387.
^ abcdVertuani S, Angusti A, Manfredini S (2004). “The antioxidants and pro-antioxidants network: an overview”. Curr Pharm Des10 (14): 1677–94. doi:10.2174/1381612043384655. PMID 15134565. https://doi.org/10.2174/1381612043384655.
^吉川春寿、芦田淳編著、「抗酸化剤」『総合栄養学辞典』、ハンディ版、第四版、同文書院、p183.(1995) ISBN 4-8103-0024-2
^ abフェントン試薬、『理化学辞典』、第5版CD-ROM版、岩波書店、1996.
^Fenton H.J.H. (1894). “Oxidation of tartaric acid in presence of iron”. J. Chem. Soc., Trans.65 (65): 899–911. doi:10.1039/ct8946500899. https://doi.org/10.1039/ct8946500899.
^Benzie, IF (2003). “Evolution of dietary antioxidants”. Comparative biochemistry and physiology. Part A, Molecular & integrative physiology136 (1): 113–26. doi:10.1016/S1095-6433(02)00368-9. PMID 14527634.
^奥田 拓道、『健康・栄養食品事典―機能性食品・特定保健用食品 』、漢方医薬新聞編集部、東洋医学社(2006) ISBN 4-88580-153-2
^Baillie, J K; A A R Thompson, J B Irving, M G D Bates, A I Sutherland, W Macnee, S R J Maxwell, D J Webb (2009-03-09). “Oral antioxidant supplementation does not prevent acute mountain sickness: double blind, randomized placebo-controlled trial”. QJM: Monthly Journal of the Association of Physicians102 (5): 341–8. doi:10.1093/qjmed/hcp026. ISSN 1460-2393. PMID 19273551. http://www.ncbi.nlm.nih.gov/pubmed/192735512009年3月25日閲覧。.
^Bjelakovic G; Nikolova, D; Gluud, LL; Simonetti, RG; Gluud, C (2007). “Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis”. JAMA297 (8): 842–57. doi:10.1001/jama.297.8.842. PMID 17327526.
^Matill HA (1947). Antioxidants. Annu Rev Biochem 16: 177–192.
^ 冨永 博夫、「潤滑油」、『世界大百科事典』、第二版CD-ROM版、平凡社、1998.
^Jacob R (1996). “Three eras of vitamin C discovery”. Subcell Biochem25: 1–16. PMID 8821966.
^Knight J (1998). “Free radicals: their history and current status in aging and disease”. Ann Clin Lab Sci28 (6): 331–46. PMID 9846200.
^ ab吉川春寿、芦田淳編著、「栄養学史年表」『総合栄養学辞典』、ハンディ版、第四版、同文書院、pp.765-776.(1995) ISBN 4-8103-0024-2
^Moreau and Dufraisse, (1922) Comptes Rendus des Séances et Mémoires de la Société de Biologie, 86, 321.
^Wolf G (1 March 2005). “The discovery of the antioxidant function of vitamin E: the contribution of Henry A. Mattill”. J Nutr135 (3): 363–6. doi:10.1093/jn/135.3.363. PMID 15735064. https://doi.org/10.1093/jn/135.3.363.
^吉川春寿、芦田淳編著、「ビタミンE」『総合栄養学辞典』、ハンディ版、第四版、同文書院、p.613.(1995) ISBN 4-8103-0024-2
^German J (1999). “Food processing and lipid oxidation”. Adv Exp Med Biol459: 23–50. doi:10.1007/978-1-4615-4853-9_3. PMID 10335367.
^ abValko M, Leibfritz D, Moncol J, Cronin M, Mazur M, Telser J (2007). “Free radicals and antioxidants in normal physiological functions and human disease”. Int J Biochem Cell Biol39 (1): 44–84. doi:10.1016/j.biocel.2006.07.001. PMID 16978905. https://doi.org/10.1016/j.biocel.2006.07.001.
^Stohs S, Bagchi D (1995). “Oxidative mechanisms in the toxicity of metal ions”. Free Radic Biol Med18 (2): 321–36. doi:10.1016/0891-5849(94)00159-H. PMID 7744317.
^Nakabeppu Y, Sakumi K, Sakamoto K, Tsuchimoto D, Tsuzuki T, Nakatsu Y (2006). “Mutagenesis and carcinogenesis caused by the oxidation of nucleic acids”. Biol Chem387 (4): 373–9. doi:10.1515/BC.2006.050. PMID 16606334.
^Valko M, Izakovic M, Mazur M, Rhodes C, Telser J (2004). “Role of oxygen radicals in DNA damage and cancer incidence”. Mol Cell Biochem266 (1–2): 37–56. doi:10.1023/B:MCBI.0000049134.69131.89. PMID 15646026.
^Stadtman E (1992). “Protein oxidation and aging”. Science257 (5074): 1220–4. doi:10.1126/science.1355616. PMID 1355616.
^Raha S, Robinson B (2000). “Mitochondria, oxygen free radicals, disease and aging”. Trends Biochem Sci25 (10): 502–8. doi:10.1016/S0968-0004(00)01674-1. PMID 11050436.
^Lenaz G (2001). “The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology”. IUBMB Life52 (3–5): 159–64. doi:10.1080/15216540152845957. PMID 11798028.
^Finkel T, Holbrook NJ (2000). “Oxidants, oxidative stress and the biology of aging”. Nature408 (6809): 239–47. doi:10.1038/35041687. PMID 11089981.
^Hirst J, King MS, Pryde KR (October 2008). “The production of reactive oxygen species by complex I”. Biochem. Soc. Trans.36 (Pt 5): 976–80. doi:10.1042/BST0360976. PMID 18793173.
^Seaver LC, Imlay JA (November 2004). “Are respiratory enzymes the primary sources of intracellular hydrogen peroxide?”. J. Biol. Chem.279 (47): 48742–50. doi:10.1074/jbc.M408754200. PMID 15361522. http://www.jbc.org/cgi/pmidlookup?view=long&pmid=15361522.
^Imlay JA (2003). “Pathways of oxidative damage”. Annu. Rev. Microbiol.57: 395–418. doi:10.1146/annurev.micro.57.030502.090938. PMID 14527285.
^Demmig-Adams B, Adams WW (December 2002). “Antioxidants in photosynthesis and human nutrition”. Science (journal)298 (5601): 2149–53. doi:10.1126/science.1078002. PMID 12481128.
^Demmig-Adams B, Adams WW (December 2002). “Antioxidants in photosynthesis and human nutrition”. Science (journal)298 (5601): 2149–53. doi:10.1126/science.1078002. PMID 12481128.
^Szabó I, Bergantino E, Giacometti G (2005). “Light and oxygenic photosynthesis: energy dissipation as a protection mechanism against photo-oxidation”. EMBO Rep6 (7): 629–34. doi:10.1038/sj.embor.7400460. PMC: 1369118. PMID 15995679. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1369118/.
^Kerfeld CA (October 2004). “Water-soluble carotenoid proteins of cyanobacteria”. Arch. Biochem. Biophys.430 (1): 2–9. doi:10.1016/j.abb.2004.03.018. PMID 15325905.
^Ames B, Cathcart R, Schwiers E, Hochstein P (1981). “Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis”. Proc Natl Acad Sci USA78 (11): 6858–62. doi:10.1073/pnas.78.11.6858. PMC: 349151. PMID 6947260. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC349151/.
^Khaw K, Woodhouse P (1995). “Interrelation of vitamin C, infection, haemostatic factors, and cardiovascular disease”. BMJ310 (6994): 1559 – 63. doi:10.1136/bmj.310.6994.1559. PMC: 2549940. PMID 7787643. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2549940/.
^ abcdEvelson P, Travacio M, Repetto M, Escobar J, Llesuy S, Lissi E (2001). “Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols”. Arch Biochem Biophys388 (2): 261 – 6. doi:10.1006/abbi.2001.2292. PMID 11368163.
^Teichert J, Preiss R (1992). “HPLC-methods for determination of lipoic acid and its reduced form in human plasma”. Int J Clin Pharmacol Ther Toxicol30 (11): 511 – 2. PMID 1490813.
^Akiba S, Matsugo S, Packer L, Konishi T (1998). “Assay of protein-bound lipoic acid in tissues by a new enzymatic method”. Anal Biochem258 (2): 299 – 304. doi:10.1006/abio.1998.2615. PMID 9570844.
^ abGlantzounis G, Tsimoyiannis E, Kappas A, Galaris D (2005). “Uric acid and oxidative stress”. Curr Pharm Des11 (32): 4145 – 51. doi:10.2174/138161205774913255. PMID 16375736.
^Normal Reference Range Table Archived 2011年12月25日, at the Wayback Machine. from The University of Texas Southwestern Medical Center at Dallas. Used in Interactive Case Study Companion to Pathologic basis of disease.
^Golonka, Debby. “Digestive Disorders Health Center: Bilirubin”. en:WebMD. pp. 3. 2010年1月14日閲覧。
^El-Sohemy A, Baylin A, Kabagambe E, Ascherio A, Spiegelman D, Campos H (2002). “Individual carotenoid concentrations in adipose tissue and plasma as biomarkers of dietary intake”. Am J Clin Nutr76 (1): 172 – 9. PMID 12081831.
^ abSowell A, Huff D, Yeager P, Caudill S, Gunter E (1994). “Retinol, alpha-tocopherol, lutein/zeaxanthin, beta-cryptoxanthin, lycopene, alpha-carotene, trans-beta-carotene, and four retinyl esters in serum determined simultaneously by reversed-phase HPLC with multiwavelength detection”. Clin Chem40 (3): 411 – 6. PMID 8131277. http://clinchem.aaccjnls.org/content/40/3/411.short.
^Stahl W, Schwarz W, Sundquist A, Sies H (1992). “cis-trans isomers of lycopene and beta-carotene in human serum and tissues”. Arch Biochem Biophys294 (1): 173 – 7. doi:10.1016/0003-9861(92)90153-N. PMID 1550343.
^Zita C, Overvad K, Mortensen S, Sindberg C, Moesgaard S, Hunter D (2003). “Serum coenzyme Q10 concentrations in healthy men supplemented with 30 mg or 100 mg coenzyme Q10 for two months in a randomised controlled study”. Biofactors18 (1 – 4): 185 – 93. doi:10.1002/biof.5520180221. PMID 14695934.
^ abTurunen M, Olsson J, Dallner G (2004). “Metabolism and function of coenzyme Q”. Biochim Biophys Acta1660 (1 – 2): 171 – 99. doi:10.1016/j.bbamem.2003.11.012. PMID 14757233.
^Miller RA, Britigan BE (January 1997). “Role of oxidants in microbial pathophysiology”. Clin. Microbiol. Rev.10 (1): 1–18. PMC: 172912. PMID 8993856. http://cmr.asm.org/cgi/pmidlookup?view=long&pmid=8993856.
^Chaudière J, Ferrari-Iliou R (1999). “Intracellular antioxidants: from chemical to biochemical mechanisms”. Food Chem Toxicol37 (9–10): 949 – 62. doi:10.1016/S0278-6915(99)00090-3. PMID 10541450.
^Sies H (1993). “Strategies of antioxidant defense”. Eur J Biochem215 (2): 213 – 9. doi:10.1111/j.1432-1033.1993.tb18025.x. PMID 7688300.
^Imlay J (2003). “Pathways of oxidative damage”. Annu Rev Microbiol57: 395–418. doi:10.1146/annurev.micro.57.030502.090938. PMID 14527285.
^ abHo YS, Magnenat JL, Gargano M, Cao J (1 October 1998). “The nature of antioxidant defense mechanisms: a lesson from transgenic studies”. Environ. Health Perspect.106 (Suppl 5): 1219–28. doi:10.2307/3433989. PMC: 1533365. PMID 9788901. http://jstor.org/stable/3433989.
^Zelko I, Mariani T, Folz R (2002). “Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression”. Free Radic Biol Med33 (3): 337–49. doi:10.1016/S0891-5849(02)00905-X. PMID 12126755.
^ abBannister J, Bannister W, Rotilio G (1987). “Aspects of the structure, function, and applications of superoxide dismutase”. CRC Crit Rev Biochem22 (2): 111–80. doi:10.3109/10409238709083738. PMID 3315461.
^Johnson F, Giulivi C (2005). “Superoxide dismutases and their impact upon human health”. Mol Aspects Med26 (4–5): 340–52. doi:10.1016/j.mam.2005.07.006. PMID 16099495.
^Reaume A, Elliott J, Hoffman E, Kowall N, Ferrante R, Siwek D, Wilcox H, Flood D, Beal M, Brown R, Scott R, Snider W (1996). “Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury”. Nat Genet13 (1): 43–7. doi:10.1038/ng0596-43. PMID 8673102.
^Van Camp W, Inzé D, Van Montagu M (1997). “The regulation and function of tobacco superoxide dismutases”. Free Radic Biol Med23 (3): 515–20. doi:10.1016/S0891-5849(97)00112-3. PMID 9214590.
^Chelikani P, Fita I, Loewen P (2004). “Diversity of structures and properties among catalases”. Cell Mol Life Sci61 (2): 192–208. doi:10.1007/s00018-003-3206-5. PMID 14745498.
^Zámocký M, Koller F (1999). “Understanding the structure and function of catalases: clues from molecular evolution and in vitro mutagenesis”. Prog Biophys Mol Biol72 (1): 19–66. doi:10.1016/S0079-6107(98)00058-3. PMID 10446501.
^del Río L, Sandalio L, Palma J, Bueno P, Corpas F (1992). “Metabolism of oxygen radicals in peroxisomes and cellular implications”. Free Radic Biol Med13 (5): 557–80. doi:10.1016/0891-5849(92)90150-F. PMID 1334030.
^Hiner A, Raven E, Thorneley R, García-Cánovas F, Rodríguez-López J (2002). “Mechanisms of compound I formation in heme peroxidases”. J Inorg Biochem91 (1): 27–34. doi:10.1016/S0162-0134(02)00390-2. PMID 12121759.
^Mueller S, Riedel H, Stremmel W (15 December 1997). “Direct evidence for catalase as the predominant H2O2 -removing enzyme in human erythrocytes”. Blood90 (12): 4973–8. PMID 9389716. http://www.bloodjournal.org/cgi/content/full/90/12/4973.
^Parsonage D, Youngblood D, Sarma G, Wood Z, Karplus P, Poole L (2005). “Analysis of the link between enzymatic activity and oligomeric state in AhpC, a bacterial peroxiredoxin”. Biochemistry44 (31): 10583–92. doi:10.1021/bi050448i. PMID 16060667. PDB 1YEX
^Rhee S, Chae H, Kim K (2005). “Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling”. Free Radic Biol Med38 (12): 1543–52. doi:10.1016/j.freeradbiomed.2005.02.026. PMID 15917183.
^Wood Z, Schröder E, Robin Harris J, Poole L (2003). “Structure, mechanism and regulation of peroxiredoxins”. Trends Biochem Sci28 (1): 32–40. doi:10.1016/S0968-0004(02)00003-8. PMID 12517450.
^Claiborne A, Yeh J, Mallett T, Luba J, Crane E, Charrier V, Parsonage D (1999). “Protein-sulfenic acids: diverse roles for an unlikely player in enzyme catalysis and redox regulation”. Biochemistry38 (47): 15407–16. doi:10.1021/bi992025k. PMID 10569923.
^Neumann C, Krause D, Carman C, Das S, Dubey D, Abraham J, Bronson R, Fujiwara Y, Orkin S, Van Etten R (2003). “Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression”. Nature424 (6948): 561–5. doi:10.1038/nature01819. PMID 12891360.
^Lee T, Kim S, Yu S, Kim S, Park D, Moon H, Dho S, Kwon K, Kwon H, Han Y, Jeong S, Kang S, Shin H, Lee K, Rhee S, Yu D (2003). “Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice”. Blood101 (12): 5033–8. doi:10.1182/blood-2002-08-2548. PMID 12586629. http://www.bloodjournal.org/cgi/content/full/101/12/5033.
^Dietz K, Jacob S, Oelze M, Laxa M, Tognetti V, de Miranda S, Baier M, Finkemeier I (2006). “The function of peroxiredoxins in plant organelle redox metabolism”. J Exp Bot57 (8): 1697–709. doi:10.1093/jxb/erj160. PMID 16606633.
^Nordberg J, Arner ES (2001). “Reactive oxygen species, antioxidants, and the mammalian thioredoxin system”. Free Radic Biol Med31 (11): 1287–312. doi:10.1016/S0891-5849(01)00724-9. PMID 11728801.
^Vieira Dos Santos C, Rey P (2006). “Plant thioredoxins are key actors in the oxidative stress response”. Trends Plant Sci11 (7): 329–34. doi:10.1016/j.tplants.2006.05.005. PMID 16782394.
^Arnér E, Holmgren A (2000). “Physiological functions of thioredoxin and thioredoxin reductase”. Eur J Biochem267 (20): 6102–9. doi:10.1046/j.1432-1327.2000.01701.x. PMID 11012661. http://www.blackwell-synergy.com/doi/full/10.1046/j.1432-1327.2000.01701.x.
^ abcdMeister A, Anderson M (1983). “Glutathione”. Annu Rev Biochem52: 711 – 60. doi:10.1146/annurev.bi.52.070183.003431. PMID 6137189.
^Creissen G, Broadbent P, Stevens R, Wellburn A, Mullineaux P (1996). “Manipulation of glutathione metabolism in transgenic plants”. Biochem Soc Trans24 (2): 465–9. PMID 8736785.
^Brigelius-Flohé R (1999). “Tissue-specific functions of individual glutathione peroxidases”. Free Radic Biol Med27 (9–10): 951–65. doi:10.1016/S0891-5849(99)00173-2. PMID 10569628.
^Ho Y, Magnenat J, Bronson R, Cao J, Gargano M, Sugawara M, Funk C (1997). “Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia”. J Biol Chem272 (26): 16644–51. doi:10.1074/jbc.272.26.16644. PMID 9195979. http://www.jbc.org/cgi/content/full/272/26/16644.
^de Haan J, Bladier C, Griffiths P, Kelner M, O'Shea R, Cheung N, Bronson R, Silvestro M, Wild S, Zheng S, Beart P, Hertzog P, Kola I (1998). “Mice with a homozygous null mutation for the most abundant glutathione peroxidase, Gpx1, show increased susceptibility to the oxidative stress-inducing agents paraquat and hydrogen peroxide”. J Biol Chem273 (35): 22528–36. doi:10.1074/jbc.273.35.22528. PMID 9712879. http://www.jbc.org/cgi/content/full/273/35/22528.
^Sharma R, Yang Y, Sharma A, Awasthi S, Awasthi Y (2004). “Antioxidant role of glutathione S-transferases: protection against oxidant toxicity and regulation of stress-mediated apoptosis”. Antioxid Redox Signal6 (2): 289–300. doi:10.1089/152308604322899350. PMID 15025930.
^Hayes J, Flanagan J, Jowsey I (2005). “Glutathione transferases”. Annu Rev Pharmacol Toxicol45: 51–88. doi:10.1146/annurev.pharmtox.45.120403.095857. PMID 15822171.
^Becker BF (June 1993). “Towards the physiological function of uric acid”. Free Radic. Biol. Med.14 (6): 615–31. doi:10.1016/0891-5849(93)90143-I. PMID 8325534.
^霊長類の進化による尿酸分解活性の消失 I ヒト上科祖先での尿酸オキシダーゼの消滅Friedman TB, Polanco GE, Appold JC, Mayle JE (1985). “On the loss of uricolytic activity during primate evolution--I. Silencing of urate oxidase in a hominoid ancestor”. Comp. Biochem. Physiol., B81 (3): 653?9. PMID 3928241.
^Purine and Pyrimidine Metabolism (Eccles Health Sciences Library)
^ abPeter Proctor Similar Functions of Uric Acid and Ascorbate in ManSimilar Functions of Uric Acid and Ascorbate in Man Nature vol 228, 1970, p868.
^ abDimitroula HV, Hatzitolios AI, Karvounis HI (July 2008). “The role of uric acid in stroke: the issue remains unresolved”. Neurologist14 (4): 238–42. doi:10.1097/NRL.0b013e31815c666b. PMID 18617849.
^Smirnoff N (2001). “L-ascorbic acid biosynthesis”. Vitam Horm61: 241 – 66. doi:10.1016/S0083-6729(01)61008-2. PMID 11153268.
^Linster CL, Van Schaftingen E (2007). “Vitamin C. Biosynthesis, recycling and degradation in mammals”. FEBS J.274 (1): 1–22. doi:10.1111/j.1742-4658.2006.05607.x. PMID 17222174.
^ abMeister A (1994). “Glutathione-ascorbic acid antioxidant system in animals”. J Biol Chem269 (13): 9397 – 400. PMID 8144521.
^Wells W, Xu D, Yang Y, Rocque P (15 September 1990). “Mammalian thioltransferase (glutaredoxin) and protein disulfide isomerase have dehydroascorbate reductase activity”. J Biol Chem265 (26): 15361 – 4. PMID 2394726. http://www.jbc.org/cgi/reprint/265/26/15361.
^Padayatty S, Katz A, Wang Y, Eck P, Kwon O, Lee J, Chen S, Corpe C, Dutta A, Dutta S, Levine M (1 February 2003). “Vitamin C as an antioxidant: evaluation of its role in disease prevention”. J Am Coll Nutr22 (1): 18 – 35. PMID 12569111. オリジナルの2010年7月21日時点におけるアーカイブ。. https://web.archive.org/web/20100721110215/http://www.jacn.org/cgi/content/full/22/1/18.
^Shigeoka S, Ishikawa T, Tamoi M, Miyagawa Y, Takeda T, Yabuta Y, Yoshimura K (2002). “Regulation and function of ascorbate peroxidase isoenzymes”. J Exp Bot53 (372): 1305 – 19. doi:10.1093/jexbot/53.372.1305. PMID 11997377. http://jxb.oxfordjournals.org/cgi/content/full/53/372/1305.
^Smirnoff N, Wheeler GL (2000). “Ascorbic acid in plants: biosynthesis and function”. Crit. Rev. Biochem. Mol. Biol.35 (4): 291–314. doi:10.1080/10409230008984166. PMID 11005203.
^Meister A (1988). “Glutathione metabolism and its selective modification” (PDF). J Biol Chem263 (33): 17205 – 8. doi:10.1073/pnas.0508621102. PMID 3053703. http://www.jbc.org/cgi/reprint/263/33/17205.pdf.
^Fairlamb AH, Cerami A (1992). “Metabolism and functions of trypanothione in the Kinetoplastida”. Annu. Rev. Microbiol.46: 695–729. doi:10.1146/annurev.mi.46.100192.003403. PMID 1444271.
^Tan DX, Manchester LC, Reiter RJ, Qi WB, Karbownik M, Calvo JR (2000). “Significance of melatonin in antioxidative defense system: reactions and products”. Biological signals and receptors9 (3–4): 137–59. doi:10.1159/000014635. PMID 10899700.
^NAKAMURATakashi; SATOKatsuyuki; AKIBAMitsuo; OHNISHIMasao (2006). “Urobilinogen, as a Bile Pigment Metabolite, Has an Antioxidant Function”. Journal of Oleo Science (日本油化学会) 55 (4): 191-197. doi:10.5650/jos.55.191. NAID 130000055572.
^Baranano DE, Rao M, Ferris CD, Snyder SH (2002). “Biliverdin reductase: a major physiologic cytoprotectant”. Proc. Natl. Acad. Sci. U.S.A.99 (25): 16093–8. doi:10.1073/pnas.252626999. PMC: 138570. PMID 12456881. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138570/.
^Liu Y, Li P, Lu J, Xiong W, Oger J, Tetzlaff W, Cynader M. (2008). “Bilirubin possesses powerful immunomodulatory activity and suppresses experimental autoimmune encephalomyelitis”. J. Immunol.181 (3): 1887–97. PMID 18641326.
^ abHerrera E, Barbas C (2001). “Vitamin E: action, metabolism and perspectives”. J Physiol Biochem57 (2): 43 – 56. doi:10.1007/BF03179812. PMID 11579997.
^Packer L, Weber SU, Rimbach G (1 February 2001). “Molecular aspects of alpha-tocotrienol antioxidant action and cell signalling”. J. Nutr.131 (2): 369S–73S. PMID 11160563. http://jn.nutrition.org/cgi/content/full/131/2/369S.
^ abBrigelius-Flohé R, Traber M (1 July 1999). “Vitamin E: function and metabolism”. FASEB J13 (10): 1145 – 55. PMID 10385606. http://www.fasebj.org/cgi/content/full/13/10/1145.
^Wang X, Quinn P (1999). “Vitamin E and its function in membranes”. Prog Lipid Res38 (4): 309 – 36. doi:10.1016/S0163-7827(99)00008-9. PMID 10793887.
^Seiler A, Schneider M, Förster H, Roth S, Wirth EK, Culmsee C, Plesnila N, Kremmer E, Rådmark O, Wurst W, Bornkamm GW, Schweizer U, Conrad M (September 2008). “Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death”. Cell Metab.8 (3): 237–48. doi:10.1016/j.cmet.2008.07.005. PMID 18762024.
^Brigelius-Flohé R, Davies KJ (2007). “Is vitamin E an antioxidant, a regulator of signal transduction and gene expression, or a 'junk' food? Comments on the two accompanying papers: "Molecular mechanism of alpha-tocopherol action" by A. Azzi and "Vitamin E, antioxidant and nothing more" by M. Traber and J. Atkinson”. Free Radic. Biol. Med.43 (1): 2–3. doi:10.1016/j.freeradbiomed.2007.05.016. PMID 17561087.
^Atkinson J, Epand RF, Epand RM (2007). “Tocopherols and tocotrienols in membranes: A critical review”. Free Radic. Biol. Med.44 (5): 739–764. doi:10.1016/j.freeradbiomed.2007.11.010. PMID 18160049.
^ abAzzi A (2007). “Molecular mechanism of alpha-tocopherol action”. Free Radic. Biol. Med.43 (1): 16–21. doi:10.1016/j.freeradbiomed.2007.03.013. PMID 17561089.
^Zingg JM, Azzi A (2004). “Non-antioxidant activities of vitamin E”. Curr. Med. Chem.11 (9): 1113–33. PMID 15134510.
^Sen C, Khanna S, Roy S (2006). “Tocotrienols: Vitamin E beyond tocopherols”. Life Sci78 (18): 2088–98. doi:10.1016/j.lfs.2005.12.001. PMC: 1790869. PMID 16458936. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1790869/.
^Christen Y (1 February 2000). “Oxidative stress and Alzheimer disease”. Am J Clin Nutr71 (2): 621S–629S. doi:10.1093/ajcn/71.2.621s. PMID 10681270. https://doi.org/10.1093/ajcn/71.2.621s.
^Nunomura A, Castellani R, Zhu X, Moreira P, Perry G, Smith M (2006). “Involvement of oxidative stress in Alzheimer disease”. J Neuropathol Exp Neurol65 (7): 631–41. doi:10.1097/01.jnen.0000228136.58062.bf. PMID 16825950.
^Wood-Kaczmar A, Gandhi S, Wood N (2006). “Understanding the molecular causes of Parkinson's disease”. Trends Mol Med12 (11): 521–8. doi:10.1016/j.molmed.2006.09.007. PMID 17027339.
^Davì G, Falco A, Patrono C (2005). “Lipid peroxidation in diabetes mellitus”. Antioxid Redox Signal7 (1–2): 256–68. doi:10.1089/ars.2005.7.256. PMID 15650413.
^Giugliano D, Ceriello A, Paolisso G (1996). “Oxidative stress and diabetic vascular complications”. Diabetes Care19 (3): 257–67. doi:10.2337/diacare.19.3.257. PMID 8742574.
^Hitchon C, El-Gabalawy H (2004). “Oxidation in rheumatoid arthritis”. Arthritis Res Ther6 (6): 265–78. doi:10.1186/ar1447. PMC: 1064874. PMID 15535839. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064874/.
^Cookson M, Shaw P (1999). “Oxidative stress and motor neurone disease”. Brain Pathol9 (1): 165–86. doi:10.1111/j.1750-3639.1999.tb00217.x. PMID 9989458.
^Van Gaal L, Mertens I, De Block C (2006). “Mechanisms linking obesity with cardiovascular disease”. Nature444 (7121): 875–80. doi:10.1038/nature05487. PMID 17167476.
^Aviram M (2000). “Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases”. Free Radic Res33 Suppl: S85–97. PMID 11191279.
^Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC (1993). “Vitamin E consumption and the risk of coronary heart disease in men”. N Engl J Med328 (20): 1450–6. doi:10.1056/NEJM199305203282004. PMID 8479464.
^Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ (2003). “Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials”. Lancet361 (9374): 2017–23. doi:10.1016/S0140-6736(03)13637-9. PMID 12814711.
^Sesso HD, Buring JE, Christen WG (November 2008). “Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial”. JAMA300 (18): 2123–33. doi:10.1001/jama.2008.600. PMC: 2586922. PMID 18997197. http://jama.ama-assn.org/cgi/pmidlookup?view=long&pmid=18997197.
^Lee IM, Cook NR, Gaziano JM (July 2005). “Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial”. JAMA294 (1): 56–65. doi:10.1001/jama.294.1.56. PMID 15998891. http://jama.ama-assn.org/cgi/pmidlookup?view=long&pmid=15998891.
^Roberts LJ, Oates JA, Linton MF (2007). “The relationship between dose of vitamin E and suppression of oxidative stress in humans”. Free Radic. Biol. Med.43 (10): 1388–93. doi:10.1016/j.freeradbiomed.2007.06.019. PMC: 2072864. PMID 17936185. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2072864/.
^Bleys J, Miller E, Pastor-Barriuso R, Appel L, Guallar E (2006). “Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials”. Am. J. Clin. Nutr.84 (4): 880–7; quiz 954–5. doi:10.1093/ajcn/84.4.880. PMID 17023716. https://doi.org/10.1093/ajcn/84.4.880.
^Cook NR, Albert CM, Gaziano JM (2007). “A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study”. Arch. Intern. Med.167 (15): 1610–8. doi:10.1001/archinte.167.15.1610. PMC: 2034519. PMID 17698683. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034519/.
^Reiter R (1995). “Oxidative processes and antioxidative defense mechanisms in the aging brain”. FASEB J9 (7): 526–33. doi:10.1096/fasebj.9.7.7737461. PMID 7737461. https://doi.org/10.1096/fasebj.9.7.7737461.
^Warner D, Sheng H, Batinić-Haberle I (2004). “Oxidants, antioxidants and the ischemic brain”. J Exp Biol207 (Pt 18): 3221–31. doi:10.1242/jeb.01022. PMID 15299043. http://jeb.biologists.org/cgi/content/full/207/18/3221.
^Wilson J, Gelb A (2002). “Free radicals, antioxidants, and neurologic injury: possible relationship to cerebral protection by anesthetics”. J Neurosurg Anesthesiol14 (1): 66–79. doi:10.1097/00008506-200201000-00014. PMID 11773828.
^Lees K, Davalos A, Davis S, Diener H, Grotta J, Lyden P, Shuaib A, Ashwood T, Hardemark H, Wasiewski W, Emeribe U, Zivin J (2006). “Additional outcomes and subgroup analyses of NXY-059 for acute ischemic stroke in the SAINT I trial”. Stroke37 (12): 2970–8. doi:10.1161/01.STR.0000249410.91473.44. PMID 17068304.
^Lees K, Zivin J, Ashwood T, Davalos A, Davis S, Diener H, Grotta J, Lyden P, Shuaib A, Hårdemark H, Wasiewski W (2006). “NXY-059 for acute ischemic stroke”. N Engl J Med354 (6): 588–600. doi:10.1056/NEJMoa052980. PMID 16467546.
^Yamaguchi T, Sano K, Takakura K, Saito I, Shinohara Y, Asano T, Yasuhara H (1 January 1998). “Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group”. Stroke29 (1): 12–7. doi:10.1161/01.STR.29.1.12. PMID 9445321. https://doi.org/10.1161/01.STR.29.1.12.
^Di Matteo V, Esposito E (2003). “Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis”. Curr Drug Targets CNS Neurol Disord2 (2): 95–107. doi:10.2174/1568007033482959. PMID 12769802.
^Rao A, Balachandran B (2002). “Role of oxidative stress and antioxidants in neurodegenerative diseases”. Nutr Neurosci5 (5): 291–309. doi:10.1080/1028415021000033767. PMID 12385592.
^Kopke RD, Jackson RL, Coleman JK, Liu J, Bielefeld EC, Balough BJ (2007). “NAC for noise: from the bench top to the clinic”. Hear. Res.226 (1-2): 114–25. doi:10.1016/j.heares.2006.10.008. PMID 17184943.
^Aggarwal BB, Shishodia S (2006). “Molecular targets of dietary agents for prevention and therapy of cancer”. Biochem. Pharmacol.71 (10): 1397–421. doi:10.1016/j.bcp.2006.02.009. PMID 16563357.
^Schulz TJ, Zarse K, Voigt A, Urban N, Birringer M, Ristow M (2007). “Glucose Restriction Extends Caenorhabditis elegans Life Span by Inducing Mitochondrial Respiration and Increasing Oxidative Stress”. Cell Metab.6 (4): 280–93. doi:10.1016/j.cmet.2007.08.011. PMID 17908557.
^Barros MH, Bandy B, Tahara EB, Kowaltowski AJ (2004). “Higher respiratory activity decreases mitochondrial reactive oxygen release and increases life span in Saccharomyces cerevisiae”. J. Biol. Chem.279 (48): 49883–8. doi:10.1074/jbc.M408918200. PMID 15383542.
^ abSohal R, Mockett R, Orr W (2002). “Mechanisms of aging: an appraisal of the oxidative stress hypothesis”. Free Radic Biol Med33 (5): 575–86. doi:10.1016/S0891-5849(02)00886-9. PMID 12208343.
^ abSohal R (2002). “Role of oxidative stress and protein oxidation in the aging process”. Free Radic Biol Med33 (1): 37–44. doi:10.1016/S0891-5849(02)00856-0. PMID 12086680.
^ abRattan S (2006). “Theories of biological aging: genes, proteins, and free radicals”. Free Radic Res40 (12): 1230–8. doi:10.1080/10715760600911303. PMID 17090411.
^Green GA (December 2008). “Review: antioxidant supplements do not reduce all-cause mortality in primary or secondary prevention”. Evid Based Med13 (6): 177. doi:10.1136/ebm.13.6.177. PMID 19043035.
^Duarte TL, Lunec J (2005). “Review: When is an antioxidant not an antioxidant? A review of novel actions and reactions of vitamin C”. Free Radic. Res.39 (7): 671–86. doi:10.1080/10715760500104025. PMID 16036346.
^ abCarr A, Frei B (1 June 1999). “Does vitamin C act as a pro-oxidant under physiological conditions?”. FASEB J.13 (9): 1007–24. PMID 10336883. http://www.fasebj.org/cgi/content/full/13/9/1007.
^Stohs SJ, Bagchi D (1995). “Oxidative mechanisms in the toxicity of metal ions”. Free Radic. Biol. Med.18 (2): 321–36. doi:10.1016/0891-5849(94)00159-H. PMID 7744317.
^Schneider C (2004). “Chemistry and biology of vitamin E”. Molecular Nutrition & Food Research49 (1): 7–30. doi:10.1002/mnfr.200400049. PMID 15580660.
^Eiji Yamashita (2013). “Astaxanthin as a Medical Food”. Functional Foods in Health and Disease3 (7): 255. http://ffhdj.com/index.php/ffhd/issue/view/16.
^Hurrell R (1 September 2003). “Influence of vegetable protein sources on trace element and mineral bioavailability”. J Nutr133 (9): 2973S–7S. PMID 12949395. http://jn.nutrition.org/cgi/content/full/133/9/2973S.
^Hunt J (1 September 2003). “Bioavailability of iron, zinc, and other trace minerals from vegetarian diets”. Am J Clin Nutr78 (3 Suppl): 633S–639S. PMID 12936958. http://www.ajcn.org/cgi/content/full/78/3/633S.
^Gibson R, Perlas L, Hotz C (2006). “Improving the bioavailability of nutrients in plant foods at the household level”. Proc Nutr Soc65 (2): 160–8. doi:10.1079/PNS2006489. PMID 16672077.
^ abMosha T, Gaga H, Pace R, Laswai H, Mtebe K (1995). “Effect of blanching on the content of antinutritional factors in selected vegetables”. Plant Foods Hum Nutr47 (4): 361–7. doi:10.1007/BF01088275. PMID 8577655.
^Sandberg A (2002). “Bioavailability of minerals in legumes”. Br J Nutr88 (Suppl 3): S281–5. doi:10.1079/BJN/2002718. PMID 12498628.
^ abBeecher G (1 October 2003). “Overview of dietary flavonoids: nomenclature, occurrence and intake”. J Nutr133 (10): 3248S–3254S. PMID 14519822. http://jn.nutrition.org/cgi/content/full/133/10/3248S.
^Prashar A, Locke I, Evans C (2006). “Cytotoxicity of clove (Syzygium aromaticum) oil and its major components to human skin cells”. Cell Prolif39 (4): 241–8. doi:10.1111/j.1365-2184.2006.00384.x. PMID 16872360.
^Hornig D, Vuilleumier J, Hartmann D (1980). “Absorption of large, single, oral intakes of ascorbic acid”. Int J Vitam Nutr Res50 (3): 309–14. PMID 7429760.
^Omenn G, Goodman G, Thornquist M, Balmes J, Cullen M, Glass A, Keogh J, Meyskens F, Valanis B, Williams J, Barnhart S, Cherniack M, Brodkin C, Hammar S (1996). “Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial”. J Natl Cancer Inst88 (21): 1550–9. doi:10.1093/jnci/88.21.1550. PMID 8901853.
^Albanes D (1 June 1999). “Beta-carotene and lung cancer: a case study”. Am J Clin Nutr69 (6): 1345S–50S. doi:10.1093/ajcn/69.6.1345S. PMID 10359235. https://doi.org/10.1093/ajcn/69.6.1345S.
^ abBjelakovic G, Nikolova D, Gluud L, Simonetti R, Gluud C (2007). “Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention: Systematic Review and Meta-analysis”. JAMA297 (8): 842–57. doi:10.1001/jama.297.8.842. PMID 17327526. http://jama.ama-assn.org/cgi/content/abstract/297/8/842.
^Study Citing Antioxidant Vitamin Risks Based On Flawed Methodology, Experts Argue News release from オレゴン州立大学 published on ScienceDaily, Accessed 19 April 2007
^Bjelakovic, G; Nikolova, D; Gluud, LL; Simonetti, RG; Gluud, C (2008). “Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases”. Cochrane Database of Systematic Reviews (2): CD007176. doi:10.1002/14651858.CD007176. PMID 18425980.
^Miller E, Pastor-Barriuso R, Dalal D, Riemersma R, Appel L, Guallar E (2005). “Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality”. Ann Intern Med142 (1): 37–46. PMID 15537682.
^Bjelakovic G, Nagorni A, Nikolova D, Simonetti R, Bjelakovic M, Gluud C (2006). “Meta-analysis: antioxidant supplements for primary and secondary prevention of colorectal adenoma”. Aliment Pharmacol Ther24 (2): 281–91. doi:10.1111/j.1365-2036.2006.02970.x. PMID 16842454.
^ abHercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, Roussel AM, Favier A, Briancon S (2004). “The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals”. Arch Intern Med164 (21): 2335–42. doi:10.1001/archinte.164.21.2335. PMID 15557412.
^Caraballoso M, Sacristan M, Serra C, Bonfill X (2003). “Drugs for preventing lung cancer in healthy people”. Cochrane Database Syst Rev (2): CD002141. doi:10.1002/14651858.CD002141. PMID 12804424.
^Coulter I, Hardy M, Morton S, Hilton L, Tu W, Valentine D, Shekelle P (2006). “Antioxidants vitamin C and vitamin e for the prevention and treatment of cancer”. Journal of general internal medicine: official journal of the Society for Research and Education in Primary Care Internal Medicine21 (7): 735–44. doi:10.1111/j.1525-1497.2006.00483.x. PMC: 1924689. PMID 16808775. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1924689/.
^ abcdStanner SA, Hughes J, Kelly CN, Buttriss J (2004). “A review of the epidemiological evidence for the 'antioxidant hypothesis'”. Public Health Nutr7 (3): 407–22. doi:10.1079/PHN2003543. PMID 15153272.
^ abcShenkin A (2006). “The key role of micronutrients”. Clin Nutr25 (1): 1–13. doi:10.1016/j.clnu.2005.11.006. PMID 16376462.
^Radimer K, Bindewald B, Hughes J, Ervin B, Swanson C, Picciano M (2004). “Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999–2000”. Am J Epidemiol160 (4): 339–49. doi:10.1093/aje/kwh207. PMID 15286019. http://aje.oxfordjournals.org/cgi/content/full/160/4/339.
^Latruffe N, Delmas D, Jannin B, Cherkaoui Malki M, Passilly-Degrace P, Berlot JP (December 2002). “Molecular analysis on the chemopreventive properties of resveratrol, a plant polyphenol microcomponent”. Int. J. Mol. Med.10 (6): 755–60. PMID 12430003. https://doi.org/10.3892/ijmm.10.6.755.
^Woodside J, McCall D, McGartland C, Young I (2005). “Micronutrients: dietary intake v. supplement use”. Proc Nutr Soc64 (4): 543–53. doi:10.1079/PNS2005464. PMID 16313697.
^ abcHail N, Cortes M, Drake EN, Spallholz JE (July 2008). “Cancer chemoprevention: a radical perspective”. Free Radic. Biol. Med.45 (2): 97–110. doi:10.1016/j.freeradbiomed.2008.04.004. PMID 18454943.
^Virgili F, Marino M (November 2008). “Regulation of cellular signals from nutritional molecules: a specific role for phytochemicals, beyond antioxidant activity”. Free Radical Biology & Medicine45 (9): 1205–16. doi:10.1016/j.freeradbiomed.2008.08.001. PMID 18762244.
^Valko M, Morris H, Cronin MT (2005). “Metals, toxicity and oxidative stress”. Curr. Med. Chem.12 (10): 1161–208. doi:10.2174/0929867053764635. PMID 15892631.
^Schneider C (2005). “Chemistry and biology of vitamin E”. Mol Nutr Food Res49 (1): 7–30. doi:10.1002/mnfr.200400049. PMID 15580660.
^Halliwell, B (2008). “Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies?”. Archives of Biochemistry and Biophysics476 (2): 107–112. doi:10.1016/j.abb.2008.01.028. PMID 18284912.
^World Cancer Research Fund and American Institute for Cancer Research (2007). Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Amer. Inst. for Cancer Research. ISBN 978-0972252225. http://wcrf.org/int/research-we-fund/continuous-update-project-cup/second-expert-report 日本語要旨:食べもの、栄養、運動とがん予防、世界がん研究基金と米国がん研究機構
^Cherubini A, Vigna G, Zuliani G, Ruggiero C, Senin U, Fellin R (2005). “Role of antioxidants in atherosclerosis: epidemiological and clinical update”. Curr Pharm Des11 (16): 2017–32. doi:10.2174/1381612054065783. PMID 15974956.
^Lotito SB, Frei B (2006). “Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon?”. Free Radic. Biol. Med.41 (12): 1727–46. doi:10.1016/j.freeradbiomed.2006.04.033. PMID 17157175.
^Lemonick, M.D. (1999年7月19日). “Diet and cancer: can food fend off tumors?”. Times Inc.. 2009年10月20日閲覧。
^“第5回 健康食品フォーラム報告書「健康食品の臨床利用と安全性」”. 財団法人医療経済研究・社会保険福祉協会. pp. 42. 2012年3月13日時点のオリジナル[リンク切れ]よりアーカイブ。2010年12月8日閲覧。
^G. López-Lluch, N. Hunt, B. Jones, M. Zhu, H. Jamieson, S. Hilmer, M. V. Cascajo, J. Allard, D. K. Ingram, P. Navas, and R. de Cabo (2006). “Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency”. Proc Natl Acad Sci USA103 (6): 1768–1773. doi:10.1073/pnas.0510452103. PMC: 1413655. PMID 16446459. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1413655/.
^Larsen P (1993). “Aging and resistance to oxidative damage in Caenorhabditis elegans”. Proc Natl Acad Sci USA90 (19): 8905–9. doi:10.1073/pnas.90.19.8905. PMC: 47469. PMID 8415630. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC47469/.
^Helfand S, Rogina B (2003). “Genetics of aging in the fruit fly, Drosophila melanogaster”. Annu Rev Genet37: 329–48. doi:10.1146/annurev.genet.37.040103.095211. PMID 14616064.
^Pérez, Viviana I.; Bokov, A; Van Remmen, H; Mele, J; Ran, Q; Ikeno, Y; Richardson, A (2009). “Is the oxidative stress theory of aging dead?”. Biochimica et Biophysica Acta (BBA) - General Subjects1790 (10): 1005–1014. doi:10.1016/j.bbagen.2009.06.003. PMC: 2789432. PMID 19524016. https://doi.org/10.1016/j.bbagen.2009.06.0032009年9月14日閲覧。.
^Dekkers J, van Doornen L, Kemper H (1996). “The role of antioxidant vitamins and enzymes in the prevention of exercise-induced muscle damage”. Sports Med21 (3): 213–38. doi:10.2165/00007256-199621030-00005. PMID 8776010.
^Tiidus P (1998). “Radical species in inflammation and overtraining”. Can J Physiol Pharmacol76 (5): 533–8. doi:10.1139/y98-047. PMID 9839079. https://doi.org/10.1139/y98-047.
^Ristow M, Zarse K, Oberbach A (May 2009). “Antioxidants prevent health-promoting effects of physical exercise in humans”. Proc. Natl. Acad. Sci. U.S.A.106 (21): 8665–70. doi:10.1073/pnas.0903485106. PMC: 2680430. PMID 19433800. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680430/.
^Leeuwenburgh C, Fiebig R, Chandwaney R, Ji L (1994). “Aging and exercise training in skeletal muscle: responses of glutathione and antioxidant enzyme systems”. Am J Physiol267 (2 Pt 2): R439–45. doi:10.1152/ajpregu.1994.267.2.R439. PMID 8067452. https://doi.org/10.1152/ajpregu.1994.267.2.R439.
^Leeuwenburgh C, Heinecke J (2001). “Oxidative stress and antioxidants in exercise”. Curr Med Chem8 (7): 829–38. doi:10.2174/0929867013372896. PMID 11375753. https://doi.org/10.2174/0929867013372896.
^Takanami Y, Iwane H, Kawai Y, Shimomitsu T (2000). “Vitamin E supplementation and endurance exercise: are there benefits?”. Sports Med29 (2): 73–83. doi:10.2165/00007256-200029020-00001. PMID 10701711.
^Mastaloudis A, Traber M, Carstensen K, Widrick J (2006). “Antioxidants did not prevent muscle damage in response to an ultramarathon run”. Med Sci Sports Exerc38 (1): 72–80. doi:10.1249/01.mss.0000188579.36272.f6. PMID 16394956.
^Peake J (2003). “Vitamin C: effects of exercise and requirements with training”. Int J Sport Nutr Exerc Metab13 (2): 125–51. doi:10.1123/ijsnem.13.2.125. PMID 12945825. https://doi.org/10.1123/ijsnem.13.2.125.
^Jakeman P, Maxwell S (1993). “Effect of antioxidant vitamin supplementation on muscle function after eccentric exercise”. Eur J Appl Physiol Occup Physiol67 (5): 426–30. doi:10.1007/BF00376459. PMID 8299614.
^Close G, Ashton T, Cable T, Doran D, Holloway C, McArdle F, MacLaren D (2006). “Ascorbic acid supplementation does not attenuate post-exercise muscle soreness following muscle-damaging exercise but may delay the recovery process”. Br J Nutr95 (5): 976–81. doi:10.1079/BJN20061732. PMID 16611389.
^Schumacker P (2006). “Reactive oxygen species in cancer cells: Live by the sword, die by the sword”. Cancer Cell10 (3): 175–6. doi:10.1016/j.ccr.2006.08.015. PMID 16959608.
^Seifried H, McDonald S, Anderson D, Greenwald P, Milner J (1 August 2003). “The antioxidant conundrum in cancer”. Cancer Res63 (15): 4295–8. PMID 12907593. http://cancerres.aacrjournals.org/cgi/content/full/63/15/4295.
^Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, Blumberg JB (June 2008). “Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?”. J. Natl. Cancer Inst.100 (11): 773–83. doi:10.1093/jnci/djn148. PMID 18505970.
^Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C (September 2008). “Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials”. Int. J. Cancer123 (6): 1227–39. doi:10.1002/ijc.23754. PMID 18623084.
^Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C (August 2007). “Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials”. Cancer Treat. Rev.33 (5): 407–18. doi:10.1016/j.ctrv.2007.01.005. PMID 17367938.
^ Der Petkau-Effekt und unsere strahlende Zukunft (『ペトカウ効果と我らの晴れやかなる未来』)、1985年、ドイツ語
^ ab 肥田舜太郎・竹野内真理「福島原発事故のさなかに-本書の概略と意義-」(抜粋)、2011年6月9日、あけび書房『人間と環境への低レベル放射能の脅威 福島原発放射能汚染を考えるために』の序文
^Ou B, Hampsch-Woodill M, Prior R (2001). “Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe”. J Agric Food Chem49 (10): 4619–26. doi:10.1021/jf010586o. PMID 11599998.
^EFSA Panel on Dietetic Products, Nutrition and Allergies (2010). “Scientific Opinion on the substantiation of health claims related to various food(s)/food constituent(s) and protection of cells from premature aging, antioxidant activity, antioxidant content and antioxidant properties, and protection of DNA, proteins and lipids from oxidative damage pursuant to Article 13(1) of Regulation (EC) No 1924/20061”. EFSA Journal8 (2): 1489. http://www.efsa.europa.eu/en/efsajournal/pub/1489.htm.
^“Withdrawn: Oxygen Radical Absorbance Capacity (ORAC) of Selected Foods, Release 2 (2010)”. United States Department of Agriculture, Agricultural Research Service (2012年5月16日). 2012年6月13日閲覧。
^Prior R, Wu X, Schaich K (2005). “Standardized methods for the determination of antioxidant capacity and phenolics in foods and dietary supplements”. J Agric Food Chem53 (10): 4290–302. doi:10.1021/jf0502698. PMID 15884874.
^Xianquan S, Shi J, Kakuda Y, Yueming J (2005). “Stability of lycopene during food processing and storage”. J Med Food8 (4): 413–22. doi:10.1089/jmf.2005.8.413. PMID 16379550.
^Rodriguez-Amaya D (2003). “Food carotenoids: analysis, composition and alterations during storage and processing of foods”. Forum Nutr56: 35–7. PMID 15806788.
^Baublis A, Lu C, Clydesdale F, Decker E (1 June 2000). “Potential of wheat-based breakfast cereals as a source of dietary antioxidants”. J Am Coll Nutr19 (3 Suppl): 308S–311S. doi:10.1080/07315724.2000.10718965. PMID 10875602. https://doi.org/10.1080/07315724.2000.10718965.
^Rietveld A, Wiseman S (1 October 2003). “Antioxidant effects of tea: evidence from human clinical trials”. J Nutr133 (10): 3285S–3292S. doi:10.1093/jn/133.10.3285S. PMID 14519827. https://doi.org/10.1093/jn/133.10.3285S.
^Maiani G, Periago Castón MJ, Catasta G (November 2008). “Carotenoids: Actual knowledge on food sources, intakes, stability and bioavailability and their protective role in humans”. Mol Nutr Food Res53: NA. doi:10.1002/mnfr.200800053. PMID 19035552.
^Henry C, Heppell N (2002). “Nutritional losses and gains during processing: future problems and issues”. Proc Nutr Soc61 (1): 145–8. doi:10.1079/PNS2001142. PMID 12002789. http://journals.cambridge.org/production/action/cjoGetFulltext?fulltextid=804076.
^“Antioxidants and Cancer Prevention: Fact Sheet”. National Cancer Institute. 2007年2月27日閲覧。
^Ortega RM (2006). “Importance of functional foods in the Mediterranean diet”. Public Health Nutr9 (8A): 1136–40. doi:10.1017/S1368980007668530. PMID 17378953.
^Goodrow EF, Wilson TA, Houde SC (October 2006). “Consumption of one egg per day increases serum lutein and zeaxanthin concentrations in older adults without altering serum lipid and lipoprotein cholesterol concentrations”. J. Nutr.136 (10): 2519–24. doi:10.1093/jn/136.10.2519. PMID 16988120. https://doi.org/10.1093/jn/136.10.2519.
^Witschi A, Reddy S, Stofer B, Lauterburg B (1992). “The systemic availability of oral glutathione”. Eur J Clin Pharmacol43 (6): 667–9. doi:10.1007/BF02284971. PMID 1362956.
^Flagg EW, Coates RJ, Eley JW (1994). “Dietary glutathione intake in humans and the relationship between intake and plasma total glutathione level”. Nutr Cancer21 (1): 33–46. doi:10.1080/01635589409514302. PMID 8183721.
^ abDodd S, Dean O, Copolov DL, Malhi GS, Berk M (December 2008). “N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility”. Expert Opin Biol Ther8 (12): 1955–62. doi:10.1517/14728220802517901. PMID 18990082.
^van de Poll MC, Dejong CH, Soeters PB (June 2006). “Adequate range for sulfur-containing amino acids and biomarkers for their excess: lessons from enteral and parenteral nutrition”. J. Nutr.136 (6 Suppl): 1694S–1700S. PMID 16702341.
^Wu G, Fang YZ, Yang S, Lupton JR, Turner ND (March 2004). “Glutathione metabolism and its implications for health”. J. Nutr.134 (3): 489–92. PMID 14988435. https://doi.org/10.1093/jn/134.3.489.
^Pan MH, Ho CT (November 2008). “Chemopreventive effects of natural dietary compounds on cancer development”. Chem Soc Rev37 (11): 2558–74. doi:10.1039/b801558a. PMID 18949126.
^Kader A, Zagory D, Kerbel E (1989). “Modified atmosphere packaging of fruits and vegetables”. Crit Rev Food Sci Nutr28 (1): 1–30. doi:10.1080/10408398909527490. PMID 2647417.
^Zallen E, Hitchcock M, Goertz G (1975). “Chilled food systems. Effects of chilled holding on quality of beef loaves”. J Am Diet Assoc67 (6): 552–7. PMID 1184900.
^Iverson F (1995). “Phenolic antioxidants: Health Protection Branch studies on butylated hydroxyanisole”. Cancer Lett93 (1): 49–54. doi:10.1016/0304-3835(95)03787-W. PMID 7600543.
^“E number index”. UK food guide. 2007年3月5日閲覧。
^Robards K, Kerr A, Patsalides E (1988). “Rancidity and its measurement in edible oils and snack foods. A review”. Analyst113 (2): 213–24. doi:10.1039/an9881300213. PMID 3288002.
^吉川春寿、芦田淳編著、「抗酸化剤」『総合栄養学辞典』、ハンディ版、第四版、同文書院、p267.(1995) ISBN 4-8103-0024-2
^Del Carlo M, Sacchetti G, Di Mattia C, Compagnone D, Mastrocola D, Liberatore L, Cichelli A (2004). “Contribution of the phenolic fraction to the antioxidant activity and oxidative stability of olive oil”. J Agric Food Chem52 (13): 4072–9. doi:10.1021/jf049806z. PMID 15212450.
^CE Boozer, GS Hammond, CE Hamilton (1955) "Air Oxidation of Hydrocarbons. The Stoichiometry and Fate of Inhibitors in Benzene and Chlorobenzene". Journal of the American Chemical Society, 3233–3235
…element (EpRE) to which Nrf2 binds. Our understanding of how these dietary antioxidants and possibly supplemental antioxidants effect protection against oxidative damage is still incomplete and evolving . …
…inhibitor effect upon serotonin, as well as compromise dopamine and catecholamine systems. Vitamin E has been hypothesized to exert its anxiolytic effect through protective antioxidant effects and decreasing …
…especially CHD, and cardiovascular mortality . Data are available assessing the effects of numerous vitamins, antioxidants, and homocysteine on CHD risk. Oxidation of low-density lipoprotein (LDL) particles …
… pylori through its antioxidant effect . Beta-carotene and ascorbic acid are believed to interfere with progression to cancer through their antinitrosation and antioxidant effects, and thus act as protective …
…omega-3 fatty acids plus antioxidants or a control enteral feed . The study was stopped early due to no effect and potential harm; patients receiving omega-3 fatty acids plus antioxidants had fewer ventilator-free …
Japanese Journal
酵素の抗酸化作用と体内カルシウム吸収指数に関する臨床研究
具 然和
New food industry = ニューフードインダストリー 62(4), 255-260, 2020-04